Today Consumer Action for a Strong Economy (CASE) issued a statement excoriating the Consumer Financial Protection Bureau’s (CFPB) decision […]
Among the more bizarre yet thoroughly amusing moments from the 2024 campaign was the video footage of President Biden […]
In the four months between Abraham Lincoln’s election in 1860 and Inauguration in 1861, outgoing President James Buchanan did Lincoln […]
The voters have spoken—they are ready for change. Tired of government overspending, overregulation, and excessive economic intervention, the American people […]
Rocket Mortgage – the country’s largest mortgage lender – is putting its foot down and pushing back on efforts […]
December 2, 2024 Re: Michigan HB. 5350 Minority Vice Chair Harris, and Members of the House Insurance and Financial Services […]
President-elect Trump’s nomination of Robert F. Kennedy, Jr. to lead the Department of Health and Human Services ranks among his […]
CASE issued a statement today praising President Trump’s nomination of Linda McMahon as Secretary of Education. An enormously successful business […]
Why are U.S. hospital bills so high? Learn more about how price transparency can help cut costs. CASE believes in […]
Concerts are supposed to be fun. Unfortunately, the typical excitement and anticipation of attending a show or sporting event has […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/